Justice Department Briefing 2026-07-22
Estimated reading time: 5 minutes
1. Agency Information Collection Activities; Proposed Collection; Comments Requested; Revision of a Previously Approved Collection; Title-Supplemental Information on Water Quality Considerations-ATF Form 5400.30
Sub: Justice Department
Content: The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms, and Explosives (ATF), will be submitting the following information collection request (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
2. Notice Pursuant to the National Cooperative Research and Production Act of 1993-1EdTech Consortium, Inc. (F/K/A IMS Global Learning Consortium, Inc.)
Sub: Justice Department, Antitrust Division
3. Notice Pursuant to the National Cooperative Research and Production Act of 1993-Canton Foundation (F/K/A Global Synchronizer Foundation)
Sub: Justice Department, Antitrust Division
4. Notice Pursuant to the National Cooperative Research and Production Act of 1993-OpenJS Foundation
Sub: Justice Department, Antitrust Division
5. Notice Pursuant to the National Cooperative Research and Production Act of 1993-Telemanagement Forum (TM Forum)
Sub: Justice Department, Antitrust Division
6. Notice Pursuant to the National Cooperative Research and Production Act of 1993-UHD Alliance, Inc.
Sub: Justice Department, Antitrust Division
7. Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation
Sub: Justice Department, Drug Enforcement Administration
Content: Cerilliant Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to supplementary information listed below for further drug information.
Legal Disclaimer
This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please
contact us.
Read our full
Legal Disclaimer, which also includes information on translation accuracy.
